Identify optimal HAP series scores for unresectable HCC patients undergoing TACE plus sorafenib: A Chinese multicenter observational study.
Zhu Y, Wang E, Zhao S, Han D, Zhao Y, Chen H, Zhu J, Han T, Bai Y, Lou Y, Zhang Y, Yang M, Zuo L, Fan J, Chen X, Jia J, Wu W, Ren W, Bai T, Ma S, Xu F, Tang Y, Han Y, Zhao J, Qi X, Li J, Du X, Chen D, Liu L.
Zhu Y, et al. Among authors: du x.
Front Oncol. 2023 Jan 27;12:983554. doi: 10.3389/fonc.2022.983554. eCollection 2022.
Front Oncol. 2023.
PMID: 36776366
Free PMC article.